Patients who undergo general anesthesia while receiving a specialized surgery to treat strokes have better outcomes than ...

Argentina: A recent systematic review and meta-analysis published in the Journal of Thrombosis and Thrombolysis compared ...

A recent randomized clinical trial published in JAMA Neurology found that patients with large vessel occlusion acute ischemic stroke who underwent endovascular thrombectomy under general ...

Predictors of short-term outcomes after endovascular therapy for acute ischemic stroke include age, neurologic status, and postsurgical complications, new research shows.

TNKase is administered as a single intravenous bolus over 5 seconds. The Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase) for the treatment of acute ischemic stroke (AIS) in ...

Even patients with stroke with excellent functional recovery can experience significant, adverse nonmotor outcomes 6 months ...

For more than 40 years as a researcher and clinician, Joseph Broderick has actively contributed to improvements in stroke ...

For acute ischemic stroke within 48 hours of onset, the novel sublingual combination of edaravone (Radicava) with dexborneol appeared to dramatically improve functional outcomes in the phase III TASTE ...

BASEL, Switzerland—Multiple randomized trials presented last week at the European Stroke Organisation Conference (ESOC) 2024 have bolstered the case that tenecteplase (TNK) is an effective—if not ...

Acute ischemic stroke remains one of medicine’s most time-sensitive emergencies. When blood flow to the brain becomes blocked, approximately 1.9 million neurons die each minute without intervention.